Jamp-Metformin recall in Canada: May contain NDMA above acceptable limits
In plain language
This recall involves Jamp-Metformin 500 mg and 850 mg tablets sold in Canada. It's being recalled because affected lots may contain N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot numbers on your product.
- Contact your pharmacist or healthcare provider for advice.
- Return the product as instructed by your pharmacist or healthcare provider.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Jamp-Metformin 500 mg tablet
Lot: X20283, X20284, X20286, X20287, X20288, Y00225, Y00226, Y00227, Y00228, Y00229, Y00230, Y00231, Y00232, Y01573, Y01574, Y01575, Y01576, Y01577, Y01578, Y01579, Y01580
Jamp-Metformin 850 mg tablet
Lot: X20385, X20386, X19224, X19225, X19226
Why this matters
Potential health risk from NDMA
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: X20283, X20284, X20286, X20287, X20288, Y00225, Y00226, Y00227, Y00228, Y00229, Y00230, Y00231, Y00232, Y01573, Y01574, Y01575, Y01576, Y01577, Y01578, Y01579, Y01580, X20385, X20386, X19224, X19225, X19226
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential health risk from NDMA
What should consumers do?
Stop using the product immediately. Check the lot numbers on your product. Contact your pharmacist or healthcare provider for advice. Return the product as instructed by your pharmacist or healthcare provider.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential health risk from NDMA
When was this product recalled?
This product was recalled on March 10, 2020.
Is the Jamp-Metformin brand affected by this recall?
Yes, Jamp-Metformin products are affected by this recall. This recall involves Jamp-Metformin 500 mg and 850 mg tablets sold in Canada. It's being recalled because affected lots may contain N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit. Stop using the product and follow the return steps in the official notice.